SEARCH

SEARCH BY CITATION

References

  • Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, Mcdonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C.2010.Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.Lancet Neurol.9:7793.
  • Ciafaloni E, Fox DJ, Pandya S, Westfield CP, Puzhankara S, Romitti PA, Mathews KD, Miller TM, Matthews DJ, Miller LA, Cunniff C, Druschel CM, Moxley RT.2009.Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (Md StARnet).J Pediatr.155:380385
  • Mendell JR, Shilling C, Leslie ND, Flanigan KM,Al-Dahhak R,Gastier-Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil C, Mahmoud M, Roush K, Bird L, Rankin C, Lilly H, Street N, Chandrasekar R, Weiss RB.2012.Evidence-based path to newborn screening for Duchenne muscular dystrophy.Ann Neurol.71:304313.
  • Merrick D, Stadler LK, Larner D, Smith J.2009.Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation.Dis Model Mech.2:374388.
  • Moxley RT 3rd, Ashwal S, Pandya S, Connolly A, Florence J, Matthews K, Baumbach L,McDonald C, Sussman M, Wade C.2005.Practice Parameter: Corticosteroid treatment of Duchenne dystrophy: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.Neurology.64:1320.